Zhu Wei, Han Yunfei, Cui Changxia, Xu Wenwen, Wang Xuan, Dou Xiaoxiao, Xu Linlin, Xu Yanyun, Mu Guoying
Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Ophthalmic Res. 2018;59(3):135-141. doi: 10.1159/000480242. Epub 2018 Jan 17.
The aim of this study was to analyze the effects of corneal crosslinking (CXL) combined with phototherapeutic keratectomy (PTK) and photorefractive keratectomy (PRK) in halting the progression and improving the visual function of corneal ectasia after laser in situ keratomileusis (LASIK).
PTK-PRK-CXL was performed on 14 eyes of 14 patients who developed corneal ectasia after LASIK. The visual acuity, spherical refraction and cylinder, corneal topography indices, thinnest corneal thickness (TCT), and endothelial cell count were evaluated at baseline and at 1, 3, 6, and 12 months postoperatively.
The mean uncorrected visual acuity improved significantly from 0.64 ± 0.36 logMAR preoperatively to 0.19 ± 0.12 logMAR at 12 months of follow-up (p < 0.001), while the mean best corrected visual acuity improved from 0.21 ± 0.14 logMAR at baseline to 0.04 ± 0.10 logMAR at 12 months postoperatively (p < 0.001). A significant decrease was observed in Kmax and Kmean values from 52.51 ± 6.74 and 43.55 ± 3.37 D at baseline to 45.72 ± 5.18 (p < 0.001) and 40.60 ± 3.05 D (p < 0.001) at the 1-year follow-up. The mean TCT decreased significantly from 419.07 ± 36.56 µm before treatment to 320.93 ± 39.78 µm at 12 months of follow-up (p < 0.001), and there was no significant endothelial cell loss (p > 0.05) beyond 6 months after treatment.
PTK-PRK-CXL is a promising procedure to halt the progression of post-LASIK keratectasia with significant visual quality improvement.
本研究旨在分析角膜交联术(CXL)联合光治疗性角膜切削术(PTK)和准分子激光屈光性角膜切削术(PRK)对阻止准分子原位角膜磨镶术(LASIK)后角膜扩张进展及改善其视功能的效果。
对14例LASIK术后发生角膜扩张的患者的14只眼进行PTK-PRK-CXL治疗。在基线时以及术后1、3、6和12个月评估视力、球镜度和柱镜度、角膜地形图指数、最薄角膜厚度(TCT)和内皮细胞计数。
平均未矫正视力从术前的0.64±0.36 logMAR显著提高到随访12个月时的0.19±0.12 logMAR(p<0.001),而平均最佳矫正视力从基线时的0.21±0.14 logMAR提高到术后12个月时的0.04±0.10 logMAR(p<0.001)。观察到Kmax和Kmean值从基线时的52.51±6.74 D和43.55±3.37 D显著下降至1年随访时的45.72±5.18 D(p<0.001)和40.60±3.05 D(p<0.001)。平均TCT从治疗前的419.07±36.56 µm显著下降至随访12个月时的320.93±39.78 µm(p<0.001),且治疗后6个月后内皮细胞无显著丢失(p>0.05)。
PTK-PRK-CXL是一种有前景的手术方法,可阻止LASIK术后角膜扩张的进展,并显著改善视觉质量。